Beactica's CEO, Dr Per Källblad, presents talk entitled "Targeting LSD1 in aggressive brain tumors" during Nordic Life Science Days (NLSDays) in Stockholm (10–12 September 2018).
Stay Updated
Sign up for the Beactica newsletter to receive our latest news and updates
This website uses cookies to improve your user experience. By continuing to browse this site, you agree to our use of cookies.
More informationOk